Caffeine, polyphenols, and other natural products found in coffee may help reduce the severity of non-alcoholic fatty liver disease

Residing within the human gut are trillions of bacteria and other microorganisms that can impact a variety of chronic human ailments.

The study provides evidence that this adipose tissue-brain-liver axis is opening up new approaches for treating metabolic diseases.

Study found that a drug first developed to treat Alzheimer’s disease, schizophrenia and sickle cell disease reduces obesity and fatty liver.

Almost all liver cancers develop after decades of chronic liver disease but a new discovery may lead to treatments that could break the link

The study provides evidence that adipose tissue-brain-liver axis exists in humans and opens up approaches for treating metabolic disease.

Researchers have found that a drug first developed to treat Alzheimer’s disease reduces obesity and fatty liver and improves heart function.

People with fatty liver disease who also have heart disease or who have had a stroke may have an even higher risk of dementia.